13 November 2024
13 November 2024
ImageBiopsy Lab claims the diagnostic will transform the way in which clinicians assess foot conditions.
The deal between the two is set to advance Neurochase’s Convection Enhanced Delivery designed to expedite drugs penetrating the brain.
Mouth breathing is linked to cardiovascular issues such as hypertension and sleep apnoea.
Despite this forecast growth, the viscosupplementation market faces various challenges.
The CE marking enables the company to market its spinal cord stimulation system across the EU following a US approval in 2022.
The funding round was led by Dexcom Ventures and saw contributions from CareSource Indiana and Elevate Ventures and others.
With a test currently under FDA review, Inflammatix commences a 600 patient-strong clinical trial in emergency departments.
Though prescribing climate-friendly inhalers is environmentally sound, some experts warn certain patients may be overlooked.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
